CI: cigna.com EV/EBITDA Multiple

Corporate emblem and logo of Cigna (CI)

Effective capital management and the expansion of PBM services are driving a positive trend, as reflected by The Cigna Group (CI) current EV/EBITDA level on the GURU.Markets base chart. Growth is fueled by specialty pharmacies and share buybacks, while pricing power allows the company to offset inflation. Meanwhile, the 0.00 level serves as a critical benchmark confirming the business's fundamental value, accounting for its debt load.

Cigna Health - CI Company Value to EBITDA (period 11/23/2025 - 11/10/2026)

Summary analytical data breakdowns for cigna.com (CI)

- stock price and consensus target price:
Stock Quotes Cigna Corporation|CI - Analyst Forecast Prices
- market capitalization information:
Market Capitalization Cigna Health|CI - Value Adjusted for Debt and Cash
- issuer book value statistics:
Book Value per Share Cigna|CI - Total Stockholders' Equity|Market Cap to Net Assets Ratio cigna.com|CI - Aggregate Asset Value
- debt and solvency information:
Total Debt to Capital The Cigna Group|CI - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Cigna|CI - Company Total Debt Obligations|Debts to Book Capitalization Cigna Health|CI - Long-Term Indebtedness|Company Short-Term Debt Cigna|Quick Ratio cigna.com
- financial results and valuation multiples details:
CI - Net Profit|Future Profit The Cigna Group|CI - Company Value to Net Income|Forward P/E Multiple The Cigna Group|CI - Price to Net Income Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cigna Health|CI - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months Cigna|CI - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months cigna.com|CI - Earnings growth in current year|Net earnings per share growth forecast for next year The Cigna Group
Comprehensive company analysis:Cigna Corporation CI
Product sample of cigna.com

The Cigna Group (CI) is fighting for government contracts amid aggressive dumping and regulatory pressure. Analyzing this EV/EBITDA multiple chart, an investor assesses the total enterprise value relative to operating profit before depreciation and amortization. This metric neutralizes the impact of debt loads and tax regimes, determining the asset's real value. The stability of this indicator confirms the company's resilience against aggressive market competition.

Main competitors

UnitedHealth Group Incorporated - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio AFL (American Family Life Assurance Company)|Humana Inc. - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation CNC (centene.com)|MOH: EV/EBITDA Multiple|Company Value to EBITDA Maximus Inc (MMS)|Enterprise Value to EBITDA Ratio OSCR|CLOV: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple CTEV|Enterprise Value to EBITDA Ratio yuanbaobaoxian.cn YB|EV/EBITDA Multiple HIT (Health In Tech)|Total Company Value to Operating Income Before Depreciation Ratio eHealth Inc. (EHTH)|GoHealth.com - EV/EBITDA Multiple|Enterprise Value to EBITDA Multiple NeueHealth, Inc. (NEUE)|Reliance Global Group (RELI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation LIFW|MPLN (MultiPlan) - EV/EBITDA Multiple